| 29/07/24 | 08:41:44 | 29 Jul 2024 | | Stabilisation Notice - ASTRAZENECA | RNS |
| 29/07/24 | 07:00:06 | 29 Jul 2024 | | Calquence fixed-duration combo improved 1L CLL PFS | RNS |
| 26/07/24 | 07:00:08 | 26 Jul 2024 | | ODAC reviewed Imfinzi in resectable lung cancer | RNS |
| 25/07/24 | 07:00:10 | 25 Jul 2024 | | Half-year Report | RNS |
| 15/07/24 | 07:00:03 | 15 Jul 2024 | | Acquisition of Amolyt Pharma completed | RNS |
| 01/07/24 | 15:00:01 | 1 Jul 2024 | | Total Voting Rights | RNS |
| 01/07/24 | 07:00:03 | 1 Jul 2024 | | Lynparza & Imfinzi positive CHMP in endometrial | RNS |
| 25/06/24 | 07:05:00 | 25 Jun 2024 | | Update on Imfinzi ADJUVANT BR.31 trial | RNS |
| 25/06/24 | 07:00:08 | 25 Jun 2024 | | Imfinzi improved EFS and OS in bladder cancer | RNS |
| 18/06/24 | 07:00:09 | 18 Jun 2024 | | Update on CAPItello-290 Phase III trial | RNS |
| 17/06/24 | 07:00:09 | 17 Jun 2024 | | Imfinzi approved in the US for endometrial cancer | RNS |
| 12/06/24 | 15:00:00 | 12 Jun 2024 | | Director/PDMR Shareholding | RNS |
| 05/06/24 | 07:00:06 | 5 Jun 2024 | | Acquisition of Fusion completed | RNS |
| 03/06/24 | 15:05:01 | 3 Jun 2024 | | Block listing Interim Review | RNS |
| 03/06/24 | 15:00:00 | 3 Jun 2024 | | Total Voting Rights | RNS |
| 03/06/24 | 07:00:10 | 3 Jun 2024 | | Tagrisso plus chemo recommended for approval in EU | RNS |
| 28/05/24 | 07:00:16 | 28 May 2024 | | Dato-DXd improved OS in nonsquamous lung cancer | RNS |
| 21/05/24 | 07:00:09 | 21 May 2024 | | AstraZeneca to deliver $80bn revenue by 2030 | RNS |
| 20/05/24 | 07:00:07 | 20 May 2024 | | AstraZeneca to manufacture ADCs in Singapore | RNS |
| 16/05/24 | 07:00:07 | 16 May 2024 | | SUPERNOVA Trial Met COVID-19 prevention endpoint | RNS |
| 15/05/24 | 15:00:00 | 15 May 2024 | | Director/PDMR Shareholding | RNS |
| 07/05/24 | 07:00:14 | 7 May 2024 | | AstraZeneca completes Cellectis equity investment | RNS |
| 02/05/24 | 07:00:10 | 2 May 2024 | | Calquence combination improved PFS in 1L MCL | RNS |
| 01/05/24 | 15:00:01 | 1 May 2024 | | Total Voting Rights | RNS |
| 29/04/24 | 07:05:00 | 29 Apr 2024 | | Truqap recommended for EU breast cancer approval | RNS |
| 29/04/24 | 07:00:09 | 29 Apr 2024 | | Enhertu improved PFS in HER2-low and ultralow | RNS |
| 25/04/24 | 07:00:11 | 25 Apr 2024 | | 1st Quarter Results | RNS |
| 11/04/24 | 17:30:00 | 11 Apr 2024 | | Result of AGM | RNS |
| 11/04/24 | 07:00:14 | 11 Apr 2024 | | AstraZeneca increases 2024 dividend by 7% | RNS |
| 08/04/24 | 07:00:07 | 8 Apr 2024 | | Enhertu approved in US for HER2+ solid tumours | RNS |
| 05/04/24 | 07:00:07 | 5 Apr 2024 | | Imfinzi improved OS & PFS in limited-stage SCLC | RNS |
| 02/04/24 | 15:00:00 | 2 Apr 2024 | | Total Voting Rights | RNS |
| 02/04/24 | 07:05:01 | 2 Apr 2024 | | Voydeya approved in US | RNS |
| 02/04/24 | 07:00:12 | 2 Apr 2024 | | FDA accepts Dato-DXd BLA for breast cancer | RNS |
| 25/03/24 | 07:00:05 | 25 Mar 2024 | | Ultomiris approved in the US for NMOSD | RNS |
| 19/03/24 | 07:00:09 | 19 Mar 2024 | | AstraZeneca to acquire Fusion | RNS |
| 14/03/24 | 07:00:10 | 14 Mar 2024 | | AstraZeneca to acquire Amolyt | RNS |
| 12/03/24 | 11:00:00 | 12 Mar 2024 | | Director/PDMR Shareholding | RNS |
| 07/03/24 | 11:00:01 | 7 Mar 2024 | | Notice of AGM | RNS |
| 06/03/24 | 15:05:00 | 6 Mar 2024 | | Director/PDMR Shareholding | RNS |
| 06/03/24 | 15:00:01 | 6 Mar 2024 | | Director/PDMR Shareholding | RNS |
| 04/03/24 | 07:00:06 | 4 Mar 2024 | | EMA validates Dato-DXd MAAs for NSQ NSCLC and BC | RNS |
| 01/03/24 | 15:00:00 | 1 Mar 2024 | | Total Voting Rights | RNS |
| 26/02/24 | 07:00:01 | 26 Feb 2024 | | Voydeya recommended for EU approval | RNS |
| 22/02/24 | 13:15:00 | 22 Feb 2024 | | Acquisition of Gracell completed | RNS |
| 22/02/24 | 11:00:00 | 22 Feb 2024 | | Director/PDMR Shareholding | RNS |
| 22/02/24 | 07:00:06 | 22 Feb 2024 | | AstraZeneca prices a $5bn bond offering | RNS |
| 21/02/24 | 07:00:03 | 21 Feb 2024 | | Filing of Form 20-F with SEC | RNS |
| 20/02/24 | 11:00:00 | 20 Feb 2024 | | Annual Financial Report | RNS |
| 19/02/24 | 15:00:01 | 19 Feb 2024 | | AstraZeneca completes acquisition of Icosavax | RNS |
